ArticleF1000Research2021
Current market rates for scholarly publishing services.
Article in F1000Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 51 citations in OpenAlex.
- Paying peer reviewers: benefits, risks, and challenges.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- Reformation of science publishing: the Stockholm Declaration.Royal Society open science · 2025Article
- Historiography of Scientific Publishing across Cultures and Disciplines.The Indian journal of radiology & imaging · 2025Article
- Special Issues: The roles of special issues in scholarly communication in a changing publishing landscape.Learned publishing : journal of the Association of Learned and Professional Society Publishers · 2025Article
- [Is science for everyone? bioethical challenges of current editorial practices]Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2024Article
- Maximizing Access and Minimizing Barriers to Research in Low- and Middle-Income Countries: Open Access and Health Equity.Calcified tissue international · 2024Review
- Article
- Paying reviewers and regulating the number of papers may help fix the peer-review process.F1000Research · 2024Article
- Article
- Replacing academic journals.Royal Society open science · 2023Article
- The future of academic publishing.Nature human behaviour · 2023Article
- Scientific Publishing in Biomedicine: A Brief History of Scientific Journals.International journal of endocrinology and metabolism · 2023Review
- Rapid qualitative health research from the Global South: Reflections and learnings from Argentina, Brazil, Chile, and Mexico during the COVID-19 pandemic.Frontiers in sociology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For decades, the supra-inflation increase of subscription prices for scholarly journals has concerned scholarly institutions. After years of fruitless efforts to solve this "serials crisis", open access has been proposed as the latest potential solution. However, also the prices for open access publishing are high and are rising well beyond inflation. What has been missing from the public discussion so far is a quantitative approach to determine the actual
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.